Every-other-day dosing of oral rimegepant is effective for preventive treatment of migraines
1. Rimegepant significantly reduced the mean number of migraine days per month between the last 4 weeks of treatment and ...
1. Rimegepant significantly reduced the mean number of migraine days per month between the last 4 weeks of treatment and ...
1. In this cohort of women, those who experienced migraines with aura were associated with an increased adjusted incidence rate ...
1. For patients with medication overuse headache, withdrawal and preventive medication was more effective at reducing headache than other strategy ...
1. In this multicenter study involving adult patients in the United States with a history of migraine, ubrogepant was shown ...
1. In this multicenter study involving adult patients in the United States with a history of migraine, ubrogepant was shown ...
1. Patients with migraine treated with rimegepant during an acute event had resolution of pain and their most bothersome symptoms ...
1. Patients with migraine treated with rimegepant during an acute event had resolution of pain and their most bothersome symptoms ...
1. In this randomized controlled trial, Fremanezumab slightly decreased the amount of headache free days in those with episodic migraines ...
1. Monthly injections of erenumab were associated with reduced migraine frequency, decreased use of acute migraine medication, and decreased migraine ...
1. Patients with chronic migraine receiving fremanezumab had significantly fewer migraines and headaches than those receiving placebo after 12 weeks ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.